NZ508927A - Methods and products for inducing mucosal immunity - Google Patents

Info

Publication number

NZ508927A

NZ508927A NZ508927A NZ50892799A NZ508927A NZ 508927 A NZ508927 A NZ 508927A NZ 508927 A NZ508927 A NZ 508927A NZ 50892799 A NZ50892799 A NZ 50892799A NZ 508927 A NZ508927 A NZ 508927A

Authority

NZ

New Zealand

Prior art keywords

oligonucleotide

antigen

nucleotides

administered

mucosal

Prior art date

1998-05-22

Links

• Espacenet
• Global Dossier
• Discuss

• 230000036039 immunity Effects 0.000 title claims description 46
• 230000001939 inductive effect Effects 0.000 title claims description 40
• 238000000034 method Methods 0.000 title description 37
• 108091034117 Oligonucleotide Proteins 0.000 claims abstract description 320
• 108091007433 antigens Proteins 0.000 claims abstract description 245
• 102000036639 antigens Human genes 0.000 claims abstract description 245
• 239000000427 antigen Substances 0.000 claims abstract description 244
• 150000007523 nucleic acids Chemical class 0.000 claims abstract description 84
• 239000003814 drug Substances 0.000 claims abstract description 71
• 108020004707 nucleic acids Proteins 0.000 claims abstract description 68
• 102000039446 nucleic acids Human genes 0.000 claims abstract description 68
• 239000002773 nucleotide Substances 0.000 claims abstract description 68
• 125000003729 nucleotide group Chemical group 0.000 claims abstract description 68
• 239000013598 vector Substances 0.000 claims abstract description 39
• 230000016379 mucosal immune response Effects 0.000 claims abstract description 25
• 108010049048 Cholera Toxin Proteins 0.000 claims description 157
• 102000009016 Cholera Toxin Human genes 0.000 claims description 157
• 239000002671 adjuvant Substances 0.000 claims description 129
• 208000015181 infectious disease Diseases 0.000 claims description 81
• 241000700605 Viruses Species 0.000 claims description 74
• 230000028993 immune response Effects 0.000 claims description 51
• 238000004519 manufacturing process Methods 0.000 claims description 45
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 43
• 230000002458 infectious effect Effects 0.000 claims description 42
• 230000009885 systemic effect Effects 0.000 claims description 40
• 239000000203 mixture Substances 0.000 claims description 38
• 230000004048 modification Effects 0.000 claims description 36
• 238000012986 modification Methods 0.000 claims description 36
• 238000012384 transportation and delivery Methods 0.000 claims description 33
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 31
• 108090000623 proteins and genes Proteins 0.000 claims description 30
• 102000004127 Cytokines Human genes 0.000 claims description 28
• 108090000695 Cytokines Proteins 0.000 claims description 28
• 206010028980 Neoplasm Diseases 0.000 claims description 26
• 239000000839 emulsion Substances 0.000 claims description 25
• 239000013612 plasmid Substances 0.000 claims description 25
• 229940037003 alum Drugs 0.000 claims description 24
• 238000009472 formulation Methods 0.000 claims description 24
• 229920001184 polypeptide Polymers 0.000 claims description 24
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 claims description 23
• 201000011510 cancer Diseases 0.000 claims description 21
• 239000013566 allergen Substances 0.000 claims description 20
• 239000003795 chemical substances by application Substances 0.000 claims description 20
• 102000004169 proteins and genes Human genes 0.000 claims description 20
• 150000002632 lipids Chemical class 0.000 claims description 19
• 239000013600 plasmid vector Substances 0.000 claims description 19
• 239000003053 toxin Substances 0.000 claims description 19
• 231100000765 toxin Toxicity 0.000 claims description 19
• 230000003612 virological effect Effects 0.000 claims description 18
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 claims description 17
• 206010020751 Hypersensitivity Diseases 0.000 claims description 16
• 229920000642 polymer Polymers 0.000 claims description 15
• 229920001282 polysaccharide Polymers 0.000 claims description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 14
• 239000000284 extract Substances 0.000 claims description 13
• 239000005017 polysaccharide Substances 0.000 claims description 13
• 238000001246 colloidal dispersion Methods 0.000 claims description 12
• 229930182490 saponin Natural products 0.000 claims description 12
• 150000007949 saponins Chemical class 0.000 claims description 12
• 235000017709 saponins Nutrition 0.000 claims description 12
• 241000894006 Bacteria Species 0.000 claims description 11
• 208000006673 asthma Diseases 0.000 claims description 11
• 244000045947 parasite Species 0.000 claims description 10
• 150000004713 phosphodiesters Chemical group 0.000 claims description 10
• 239000002502 liposome Substances 0.000 claims description 9
• 239000000693 micelle Substances 0.000 claims description 9
• 239000004005 microsphere Substances 0.000 claims description 9
• 208000035473 Communicable disease Diseases 0.000 claims description 8
• NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 claims description 8
• 239000005556 hormone Substances 0.000 claims description 8
• 229940088597 hormone Drugs 0.000 claims description 8
• 239000002245 particle Substances 0.000 claims description 8
• 241000233866 Fungi Species 0.000 claims description 7
• UNEIHNMKASENIG-UHFFFAOYSA-N para-chlorophenylpiperazine Chemical compound C1=CC(Cl)=CC=C1N1CCNCC1 UNEIHNMKASENIG-UHFFFAOYSA-N 0.000 claims description 7
• 230000000087 stabilizing effect Effects 0.000 claims description 7
• RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical group OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 claims description 6
• 239000011324 bead Substances 0.000 claims description 6
• 150000001720 carbohydrates Chemical class 0.000 claims description 6
• 235000014633 carbohydrates Nutrition 0.000 claims description 6
• 239000003599 detergent Substances 0.000 claims description 6
• 239000002088 nanocapsule Substances 0.000 claims description 6
• 229930186217 Glycolipid Natural products 0.000 claims description 5
• PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 3
• 239000010931 gold Substances 0.000 claims description 3
• 229910052737 gold Inorganic materials 0.000 claims description 3
• 238000011160 research Methods 0.000 claims description 3
• 208000030961 allergic reaction Diseases 0.000 claims description 2
• 230000000139 costimulatory effect Effects 0.000 claims description 2
• 150000004676 glycans Chemical class 0.000 claims 6
• 239000001397 quillaja saponaria molina bark Substances 0.000 claims 5
• 239000003643 water by type Substances 0.000 claims 1
• 238000002360 preparation method Methods 0.000 abstract description 5
• 229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 269
• CTMZLDSMFCVUNX-VMIOUTBZSA-N cytidylyl-(3'->5')-guanosine Chemical group O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(N=C(N)N3)=O)N=C2)O)[C@@H](CO)O1 CTMZLDSMFCVUNX-VMIOUTBZSA-N 0.000 description 241
• 235000011468 Albizia julibrissin Nutrition 0.000 description 56
• 241001070944 Mimosa Species 0.000 description 56
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 44
• 210000004027 cell Anatomy 0.000 description 44
• 230000004044 response Effects 0.000 description 44
• 241000699670 Mus sp. Species 0.000 description 42
• 230000000694 effects Effects 0.000 description 38
• 150000001875 compounds Chemical class 0.000 description 29
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 29
• 230000003053 immunization Effects 0.000 description 26
• 238000002649 immunization Methods 0.000 description 26
• 201000010099 disease Diseases 0.000 description 25
• 210000004072 lung Anatomy 0.000 description 25
• 230000014509 gene expression Effects 0.000 description 24
• 241001430294 unidentified retrovirus Species 0.000 description 23
• 244000052769 pathogen Species 0.000 description 22
• 241001465754 Metazoa Species 0.000 description 20
• 230000002550 fecal effect Effects 0.000 description 20
• 229960005486 vaccine Drugs 0.000 description 20
• 241000271566 Aves Species 0.000 description 18
• 238000011725 BALB/c mouse Methods 0.000 description 18
• 230000001717 pathogenic effect Effects 0.000 description 17
• 239000000243 solution Substances 0.000 description 17
• 241000283690 Bos taurus Species 0.000 description 15
• 208000026935 allergic disease Diseases 0.000 description 14
• 238000001727 in vivo Methods 0.000 description 14
• 230000006698 induction Effects 0.000 description 14
• 150000003839 salts Chemical class 0.000 description 14
• -1 alum Proteins 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 244000005700 microbiome Species 0.000 description 13
• 239000003981 vehicle Substances 0.000 description 13
• 241000588724 Escherichia coli Species 0.000 description 12
• 241000282326 Felis catus Species 0.000 description 12
• 239000007927 intramuscular injection Substances 0.000 description 12
• 239000008188 pellet Substances 0.000 description 12
• 230000002195 synergetic effect Effects 0.000 description 12
• 230000007815 allergy Effects 0.000 description 11
• 238000007918 intramuscular administration Methods 0.000 description 11
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 11
• 238000002255 vaccination Methods 0.000 description 11
• 241000725585 Chicken anemia virus Species 0.000 description 10
• 101710146739 Enterotoxin Proteins 0.000 description 10
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 10
• 239000000147 enterotoxin Substances 0.000 description 10
• 231100000655 enterotoxin Toxicity 0.000 description 10
• 210000000987 immune system Anatomy 0.000 description 10
• 108700012359 toxins Proteins 0.000 description 9
• 241000251468 Actinopterygii Species 0.000 description 8
• 108020004414 DNA Proteins 0.000 description 8
• 241000702421 Dependoparvovirus Species 0.000 description 8
• 241000282412 Homo Species 0.000 description 8
• 230000001580 bacterial effect Effects 0.000 description 8
• 230000015556 catabolic process Effects 0.000 description 8
• 238000006731 degradation reaction Methods 0.000 description 8
• 238000010790 dilution Methods 0.000 description 8
• 239000012895 dilution Substances 0.000 description 8
• 235000019688 fish Nutrition 0.000 description 8
• 210000002865 immune cell Anatomy 0.000 description 8
• 239000008194 pharmaceutical composition Substances 0.000 description 8
• 239000000725 suspension Substances 0.000 description 8
• 238000013518 transcription Methods 0.000 description 8
• 230000035897 transcription Effects 0.000 description 8
• 238000011282 treatment Methods 0.000 description 8
• 241000701022 Cytomegalovirus Species 0.000 description 7
• 241000709661 Enterovirus Species 0.000 description 7
• 241000287828 Gallus gallus Species 0.000 description 7
• 238000003556 assay Methods 0.000 description 7
• 210000003719 b-lymphocyte Anatomy 0.000 description 7
• 239000002775 capsule Substances 0.000 description 7
• 235000013330 chicken meat Nutrition 0.000 description 7
• 230000008348 humoral response Effects 0.000 description 7
• 230000003308 immunostimulating effect Effects 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 239000000047 product Substances 0.000 description 7
• 230000000638 stimulation Effects 0.000 description 7
• 239000003826 tablet Substances 0.000 description 7
• 231100000331 toxic Toxicity 0.000 description 7
• 230000002588 toxic effect Effects 0.000 description 7
• 241000701161 unidentified adenovirus Species 0.000 description 7
• 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 6
• 241000714165 Feline leukemia virus Species 0.000 description 6
• 241001631646 Papillomaviridae Species 0.000 description 6
• 241000714474 Rous sarcoma virus Species 0.000 description 6
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
• 241000282898 Sus scrofa Species 0.000 description 6
• 210000001744 T-lymphocyte Anatomy 0.000 description 6
• 239000002253 acid Substances 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
• 208000005098 feline infectious peritonitis Diseases 0.000 description 6
• BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 6
• 229960003132 halothane Drugs 0.000 description 6
• 230000001404 mediated effect Effects 0.000 description 6
• 150000004804 polysaccharides Chemical class 0.000 description 6
• 239000000126 substance Substances 0.000 description 6
• RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical class CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 6
• 241000283707 Capra Species 0.000 description 5
• 238000002965 ELISA Methods 0.000 description 5
• 241000701081 Equid alphaherpesvirus 1 Species 0.000 description 5
• 241000282324 Felis Species 0.000 description 5
• 108010010803 Gelatin Proteins 0.000 description 5
• 241000712079 Measles morbillivirus Species 0.000 description 5
• 241000699666 Mus <mouse, genus> Species 0.000 description 5
• 101710116435 Outer membrane protein Proteins 0.000 description 5
• 241001494479 Pecora Species 0.000 description 5
• 241001505332 Polyomavirus sp. Species 0.000 description 5
• 229920002472 Starch Polymers 0.000 description 5
• 208000010668 atopic eczema Diseases 0.000 description 5
• 230000037396 body weight Effects 0.000 description 5
• 239000000969 carrier Substances 0.000 description 5
• 230000009089 cytolysis Effects 0.000 description 5
• 238000011161 development Methods 0.000 description 5
• 230000018109 developmental process Effects 0.000 description 5
• 239000013604 expression vector Substances 0.000 description 5
• 239000000499 gel Substances 0.000 description 5
• 229920000159 gelatin Polymers 0.000 description 5
• 239000008273 gelatin Substances 0.000 description 5
• 235000019322 gelatine Nutrition 0.000 description 5
• 235000011852 gelatine desserts Nutrition 0.000 description 5
• 231100001231 less toxic Toxicity 0.000 description 5
• 239000000463 material Substances 0.000 description 5
• 210000004400 mucous membrane Anatomy 0.000 description 5
• 239000000546 pharmaceutical excipient Substances 0.000 description 5
• 230000003389 potentiating effect Effects 0.000 description 5
• 150000003230 pyrimidines Chemical class 0.000 description 5
• 239000011780 sodium chloride Substances 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 241000894007 species Species 0.000 description 5
• 230000001225 therapeutic effect Effects 0.000 description 5
• 231100000419 toxicity Toxicity 0.000 description 5
• 230000001988 toxicity Effects 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 241000712461 unidentified influenza virus Species 0.000 description 5
• 208000030507 AIDS Diseases 0.000 description 4
• 241001118702 Border disease virus Species 0.000 description 4
• 241000710777 Classical swine fever virus Species 0.000 description 4
• 108091029430 CpG site Proteins 0.000 description 4
• 241000712471 Dhori virus Species 0.000 description 4
• 108010042407 Endonucleases Proteins 0.000 description 4
• 241000991587 Enterovirus C Species 0.000 description 4
• 241000283086 Equidae Species 0.000 description 4
• 241000713800 Feline immunodeficiency virus Species 0.000 description 4
• 241000701047 Gallid alphaherpesvirus 2 Species 0.000 description 4
• 241000725303 Human immunodeficiency virus Species 0.000 description 4
• 108010065805 Interleukin-12 Proteins 0.000 description 4
• 102000013462 Interleukin-12 Human genes 0.000 description 4
• 108090000978 Interleukin-4 Proteins 0.000 description 4
• 108010002616 Interleukin-5 Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 229910019142 PO4 Inorganic materials 0.000 description 4
• 241000710778 Pestivirus Species 0.000 description 4
• 239000004698 Polyethylene Substances 0.000 description 4
• 241000702670 Rotavirus Species 0.000 description 4
• 101710172711 Structural protein Proteins 0.000 description 4
• 230000024932 T cell mediated immunity Effects 0.000 description 4
• 230000006052 T cell proliferation Effects 0.000 description 4
• DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 4
• 206010000210 abortion Diseases 0.000 description 4
• 231100000176 abortion Toxicity 0.000 description 4
• 238000002835 absorbance Methods 0.000 description 4
• 239000000443 aerosol Substances 0.000 description 4
• 230000000172 allergic effect Effects 0.000 description 4
• 238000010171 animal model Methods 0.000 description 4
• 244000144974 aquaculture Species 0.000 description 4
• 230000008901 benefit Effects 0.000 description 4
• 239000011230 binding agent Substances 0.000 description 4
• 230000004071 biological effect Effects 0.000 description 4
• HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
• 230000000120 cytopathologic effect Effects 0.000 description 4
• 230000002950 deficient Effects 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 239000008298 dragée Substances 0.000 description 4
• 210000003527 eukaryotic cell Anatomy 0.000 description 4
• 102000013165 exonuclease Human genes 0.000 description 4
• UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 4
• 230000001506 immunosuppresive effect Effects 0.000 description 4
• 206010022000 influenza Diseases 0.000 description 4
• 230000000813 microbial effect Effects 0.000 description 4
• 230000003472 neutralizing effect Effects 0.000 description 4
• 229920000573 polyethylene Polymers 0.000 description 4
• 229920001223 polyethylene glycol Polymers 0.000 description 4
• 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
• 229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
• 239000001267 polyvinylpyrrolidone Substances 0.000 description 4
• 244000144977 poultry Species 0.000 description 4
• 235000013594 poultry meat Nutrition 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 230000037452 priming Effects 0.000 description 4
• 230000001105 regulatory effect Effects 0.000 description 4
• 210000002345 respiratory system Anatomy 0.000 description 4
• 210000003296 saliva Anatomy 0.000 description 4
• 235000015170 shellfish Nutrition 0.000 description 4
• 210000004988 splenocyte Anatomy 0.000 description 4
• 230000002269 spontaneous effect Effects 0.000 description 4
• 239000003381 stabilizer Substances 0.000 description 4
• 235000019698 starch Nutrition 0.000 description 4
• 235000000346 sugar Nutrition 0.000 description 4
• 239000000829 suppository Substances 0.000 description 4
• 210000001519 tissue Anatomy 0.000 description 4
• 210000003437 trachea Anatomy 0.000 description 4
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• 229930024421 Adenine Natural products 0.000 description 3
• GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
• 108020000946 Bacterial DNA Proteins 0.000 description 3
• 231100000699 Bacterial toxin Toxicity 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 241000282693 Cercopithecidae Species 0.000 description 3
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
• 241000450599 DNA viruses Species 0.000 description 3
• 102000004533 Endonucleases Human genes 0.000 description 3
• 241001598169 Equid alphaherpesvirus 3 Species 0.000 description 3
• 241000725578 Equid gammaherpesvirus 2 Species 0.000 description 3
• 241000230501 Equine herpesvirus sp. Species 0.000 description 3
• 241000283073 Equus caballus Species 0.000 description 3
• 108060002716 Exonuclease Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 3
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 3
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 3
• 206010062016 Immunosuppression Diseases 0.000 description 3
• 108090000174 Interleukin-10 Proteins 0.000 description 3
• 108090001005 Interleukin-6 Proteins 0.000 description 3
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
• 241000713666 Lentivirus Species 0.000 description 3
• 241000711386 Mumps virus Species 0.000 description 3
• 101710163270 Nuclease Proteins 0.000 description 3
• 241000712464 Orthomyxoviridae Species 0.000 description 3
• 241000150218 Orthonairovirus Species 0.000 description 3
• 108091081548 Palindromic sequence Proteins 0.000 description 3
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 3
• 241000286209 Phasianidae Species 0.000 description 3
• 241000713137 Phlebovirus Species 0.000 description 3
• 241000288906 Primates Species 0.000 description 3
• 241000711798 Rabies lyssavirus Species 0.000 description 3
• 241000725643 Respiratory syncytial virus Species 0.000 description 3
• 241000712909 Reticuloendotheliosis virus Species 0.000 description 3
• 241000710799 Rubella virus Species 0.000 description 3
• 241000607142 Salmonella Species 0.000 description 3
• 241000277331 Salmonidae Species 0.000 description 3
• 241000194017 Streptococcus Species 0.000 description 3
• 241000710924 Togaviridae Species 0.000 description 3
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 3
• 241000607626 Vibrio cholerae Species 0.000 description 3
• 229960000643 adenine Drugs 0.000 description 3
• 230000000240 adjuvant effect Effects 0.000 description 3
• 230000005875 antibody response Effects 0.000 description 3
• 239000000688 bacterial toxin Substances 0.000 description 3
• 230000027455 binding Effects 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 239000000872 buffer Substances 0.000 description 3
• 229910002092 carbon dioxide Inorganic materials 0.000 description 3
• 238000004113 cell culture Methods 0.000 description 3
• 238000006243 chemical reaction Methods 0.000 description 3
• KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
• 238000000576 coating method Methods 0.000 description 3
• 229940104302 cytosine Drugs 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• 239000003937 drug carrier Substances 0.000 description 3
• 241001493065 dsRNA viruses Species 0.000 description 3
• 239000012636 effector Substances 0.000 description 3
• 230000002255 enzymatic effect Effects 0.000 description 3
• 238000011156 evaluation Methods 0.000 description 3
• 210000003608 fece Anatomy 0.000 description 3
• 239000000945 filler Substances 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 210000001035 gastrointestinal tract Anatomy 0.000 description 3
• 102000034356 gene-regulatory proteins Human genes 0.000 description 3
• 108091006104 gene-regulatory proteins Proteins 0.000 description 3
• 230000002163 immunogen Effects 0.000 description 3
• 238000010348 incorporation Methods 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 239000008101 lactose Substances 0.000 description 3
• 208000032839 leukemia Diseases 0.000 description 3
• 230000000670 limiting effect Effects 0.000 description 3
• 210000004698 lymphocyte Anatomy 0.000 description 3
• BSOQXXWZTUDTEL-ZUYCGGNHSA-N muramyl dipeptide Chemical compound OC(=O)CC[C@H](C(N)=O)NC(=O)[C@H](C)NC(=O)[C@@H](C)O[C@H]1[C@H](O)[C@@H](CO)O[C@@H](O)[C@@H]1NC(C)=O BSOQXXWZTUDTEL-ZUYCGGNHSA-N 0.000 description 3
• 239000000825 pharmaceutical preparation Substances 0.000 description 3
• 239000010452 phosphate Substances 0.000 description 3
• 239000003755 preservative agent Substances 0.000 description 3
• 230000001681 protective effect Effects 0.000 description 3
• 150000003212 purines Chemical class 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 230000003248 secreting effect Effects 0.000 description 3
• 210000002966 serum Anatomy 0.000 description 3
• 210000003491 skin Anatomy 0.000 description 3
• 239000002904 solvent Substances 0.000 description 3
• 239000000600 sorbitol Substances 0.000 description 3
• 239000006228 supernatant Substances 0.000 description 3
• 238000012385 systemic delivery Methods 0.000 description 3
• 229940113082 thymine Drugs 0.000 description 3
• 238000010361 transduction Methods 0.000 description 3
• 230000026683 transduction Effects 0.000 description 3
• 239000013638 trimer Substances 0.000 description 3
• 241001529453 unidentified herpesvirus Species 0.000 description 3
• 229940118696 vibrio cholerae Drugs 0.000 description 3
• 239000013603 viral vector Substances 0.000 description 3
• 108010042708 Acetylmuramyl-Alanyl-Isoglutamine Proteins 0.000 description 2
• 241001455214 Acinonyx jubatus Species 0.000 description 2
• 241000701242 Adenoviridae Species 0.000 description 2
• 241000701386 African swine fever virus Species 0.000 description 2
• 206010027654 Allergic conditions Diseases 0.000 description 2
• 241000219496 Alnus Species 0.000 description 2
• 241000272517 Anseriformes Species 0.000 description 2
• 241000712892 Arenaviridae Species 0.000 description 2
• 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
• 240000006891 Artemisia vulgaris Species 0.000 description 2
• 206010003645 Atopy Diseases 0.000 description 2
• 241000711404 Avian avulavirus 1 Species 0.000 description 2
• 241000714230 Avian leukemia virus Species 0.000 description 2
• 241000713838 Avian myeloblastosis virus Species 0.000 description 2
• 241000193830 Bacillus <bacterium> Species 0.000 description 2
• 208000035143 Bacterial infection Diseases 0.000 description 2
• 241001227615 Bovine foamy virus Species 0.000 description 2
• 241000714266 Bovine leukemia virus Species 0.000 description 2
• 241000711895 Bovine orthopneumovirus Species 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 208000008889 California Encephalitis Diseases 0.000 description 2
• 241000282472 Canis lupus familiaris Species 0.000 description 2
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
• 235000000509 Chenopodium ambrosioides Nutrition 0.000 description 2
• 244000098897 Chenopodium botrys Species 0.000 description 2
• 235000005490 Chenopodium botrys Nutrition 0.000 description 2
• 241001502567 Chikungunya virus Species 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 102100031673 Corneodesmosin Human genes 0.000 description 2
• 101710139375 Corneodesmosin Proteins 0.000 description 2
• 241000150230 Crimean-Congo hemorrhagic fever orthonairovirus Species 0.000 description 2
• 240000005109 Cryptomeria japonica Species 0.000 description 2
• 241000252233 Cyprinus carpio Species 0.000 description 2
• 241000725619 Dengue virus Species 0.000 description 2
• 201000004624 Dermatitis Diseases 0.000 description 2
• 241000255925 Diptera Species 0.000 description 2
• 208000000655 Distemper Diseases 0.000 description 2
• 241001115402 Ebolavirus Species 0.000 description 2
• 241000196324 Embryophyta Species 0.000 description 2
• 206010014584 Encephalitis california Diseases 0.000 description 2
• 206010066919 Epidemic polyarthritis Diseases 0.000 description 2
• 241000713730 Equine infectious anemia virus Species 0.000 description 2
• 108050001049 Extracellular proteins Proteins 0.000 description 2
• 241000714174 Feline sarcoma virus Species 0.000 description 2
• 241000192125 Firmicutes Species 0.000 description 2
• 241000710198 Foot-and-mouth disease virus Species 0.000 description 2
• 108091006027 G proteins Proteins 0.000 description 2
• 108091000058 GTP-Binding Proteins 0.000 description 2
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
• 241000713813 Gibbon ape leukemia virus Species 0.000 description 2
• 102000003886 Glycoproteins Human genes 0.000 description 2
• 108090000288 Glycoproteins Proteins 0.000 description 2
• 241000856850 Goose coronavirus Species 0.000 description 2
• 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
• 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
• 241000711549 Hepacivirus C Species 0.000 description 2
• 241000700721 Hepatitis B virus Species 0.000 description 2
• 241000709721 Hepatovirus A Species 0.000 description 2
• 208000009889 Herpes Simplex Diseases 0.000 description 2
• 241000700586 Herpesviridae Species 0.000 description 2
• 241000713673 Human foamy virus Species 0.000 description 2
• 241000701044 Human gammaherpesvirus 4 Species 0.000 description 2
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
• 241000726041 Human respirovirus 1 Species 0.000 description 2
• 241000714192 Human spumaretrovirus Species 0.000 description 2
• 241000248484 Ichthyophthirius Species 0.000 description 2
• 241000700723 Ictalurid herpesvirus 1 Species 0.000 description 2
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
• 206010061598 Immunodeficiency Diseases 0.000 description 2
• 208000029462 Immunodeficiency disease Diseases 0.000 description 2
• 108060003951 Immunoglobulin Proteins 0.000 description 2
• 241000711450 Infectious bronchitis virus Species 0.000 description 2
• 241000702626 Infectious bursal disease virus Species 0.000 description 2
• 241000711804 Infectious hematopoietic necrosis virus Species 0.000 description 2
• 241000710921 Infectious pancreatic necrosis virus Species 0.000 description 2
• 241000712431 Influenza A virus Species 0.000 description 2
• 241000701377 Iridoviridae Species 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 241000721662 Juniperus Species 0.000 description 2
• 241000710912 Kunjin virus Species 0.000 description 2
• 201000009908 La Crosse encephalitis Diseases 0.000 description 2
• 241000712899 Lymphocytic choriomeningitis mammarenavirus Species 0.000 description 2
• 241000282553 Macaca Species 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 241000713821 Mason-Pfizer monkey virus Species 0.000 description 2
• 241000713862 Moloney murine sarcoma virus Species 0.000 description 2
• 241000712045 Morbillivirus Species 0.000 description 2
• 241000714177 Murine leukemia virus Species 0.000 description 2
• 241000711941 Murine orthopneumovirus Species 0.000 description 2
• 241000711408 Murine respirovirus Species 0.000 description 2
• 241000710908 Murray Valley encephalitis virus Species 0.000 description 2
• 241001457453 Nairobi sheep disease virus Species 0.000 description 2
• 208000012266 Needlestick injury Diseases 0.000 description 2
• 241000588650 Neisseria meningitidis Species 0.000 description 2
• 241000795633 Olea <sea slug> Species 0.000 description 2
• 241000725177 Omsk hemorrhagic fever virus Species 0.000 description 2
• 101710105714 Outer surface protein A Proteins 0.000 description 2
• 241000282320 Panthera leo Species 0.000 description 2
• 241000282372 Panthera onca Species 0.000 description 2
• 241000282373 Panthera pardus Species 0.000 description 2
• 241000711504 Paramyxoviridae Species 0.000 description 2
• 241000150350 Peribunyaviridae Species 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 241000709664 Picornaviridae Species 0.000 description 2
• 241000711902 Pneumovirus Species 0.000 description 2
• 241000710884 Powassan virus Species 0.000 description 2
• 241000700625 Poxviridae Species 0.000 description 2
• 241000125945 Protoparvovirus Species 0.000 description 2
• 241000702247 Reoviridae Species 0.000 description 2
• 241000711931 Rhabdoviridae Species 0.000 description 2
• 241000606701 Rickettsia Species 0.000 description 2
• 241000713124 Rift Valley fever virus Species 0.000 description 2
• 241000711897 Rinderpest morbillivirus Species 0.000 description 2
• 241000710942 Ross River virus Species 0.000 description 2
• 241000710801 Rubivirus Species 0.000 description 2
• 206010039491 Sarcoma Diseases 0.000 description 2
• 241001529934 Simian T-lymphotropic virus 3 Species 0.000 description 2
• 241000713656 Simian foamy virus Species 0.000 description 2
• 241000700584 Simplexvirus Species 0.000 description 2
• 241000710960 Sindbis virus Species 0.000 description 2
• 208000001203 Smallpox Diseases 0.000 description 2
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
• 244000062793 Sorghum vulgare Species 0.000 description 2
• 241000713896 Spleen necrosis virus Species 0.000 description 2
• 241000710888 St. Louis encephalitis virus Species 0.000 description 2
• 229930182558 Sterol Natural products 0.000 description 2
• 241000282887 Suidae Species 0.000 description 2
• 241000725681 Swine influenza virus Species 0.000 description 2
• 241000218636 Thuja Species 0.000 description 2
• GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
• 208000024780 Urticaria Diseases 0.000 description 2
• 241000713152 Uukuniemi virus Species 0.000 description 2
• 241000700618 Vaccinia virus Species 0.000 description 2
• 206010046865 Vaccinia virus infection Diseases 0.000 description 2
• 241000710959 Venezuelan equine encephalitis virus Species 0.000 description 2
• 241000711975 Vesicular stomatitis virus Species 0.000 description 2
• 241000711970 Vesiculovirus Species 0.000 description 2
• 241000711825 Viral hemorrhagic septicemia virus Species 0.000 description 2
• 241000710951 Western equine encephalitis virus Species 0.000 description 2
• 241000714205 Woolly monkey sarcoma virus Species 0.000 description 2
• 241000710772 Yellow fever virus Species 0.000 description 2
• 150000007513 acids Chemical class 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 239000004480 active ingredient Substances 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• 108700010877 adenoviridae proteins Proteins 0.000 description 2
• 230000002411 adverse Effects 0.000 description 2
• 208000007502 anemia Diseases 0.000 description 2
• 230000000890 antigenic effect Effects 0.000 description 2
• 238000009360 aquaculture Methods 0.000 description 2
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
• 230000002238 attenuated effect Effects 0.000 description 2
• DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 2
• 210000001185 bone marrow Anatomy 0.000 description 2
• 239000006172 buffering agent Substances 0.000 description 2
• 239000001768 carboxy methyl cellulose Substances 0.000 description 2
• 230000004663 cell proliferation Effects 0.000 description 2
• 108091092356 cellular DNA Proteins 0.000 description 2
• 230000004700 cellular uptake Effects 0.000 description 2
• 239000001913 cellulose Substances 0.000 description 2
• 229920002678 cellulose Polymers 0.000 description 2
• 235000010980 cellulose Nutrition 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 235000012000 cholesterol Nutrition 0.000 description 2
• 230000001684 chronic effect Effects 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 101150006264 ctb-1 gene Proteins 0.000 description 2
• 230000007423 decrease Effects 0.000 description 2
• 230000003111 delayed effect Effects 0.000 description 2
• 210000004443 dendritic cell Anatomy 0.000 description 2
• 238000009795 derivation Methods 0.000 description 2
• 235000014113 dietary fatty acids Nutrition 0.000 description 2
• 239000002552 dosage form Substances 0.000 description 2
• 238000012377 drug delivery Methods 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 210000002919 epithelial cell Anatomy 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 239000000194 fatty acid Substances 0.000 description 2
• 229930195729 fatty acid Natural products 0.000 description 2
• 239000010685 fatty oil Substances 0.000 description 2
• 230000002496 gastric effect Effects 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 230000001894 hemadsorption Effects 0.000 description 2
• 230000028996 humoral immune response Effects 0.000 description 2
• 230000007813 immunodeficiency Effects 0.000 description 2
• 102000018358 immunoglobulin Human genes 0.000 description 2
• 238000002513 implantation Methods 0.000 description 2
• 238000000099 in vitro assay Methods 0.000 description 2
• 239000012678 infectious agent Substances 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 238000003780 insertion Methods 0.000 description 2
• 230000037431 insertion Effects 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 230000010354 integration Effects 0.000 description 2
• 230000003993 interaction Effects 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 244000144972 livestock Species 0.000 description 2
• 239000000314 lubricant Substances 0.000 description 2
• HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
• 230000003211 malignant effect Effects 0.000 description 2
• VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
• 238000010369 molecular cloning Methods 0.000 description 2
• 229940100662 nasal drops Drugs 0.000 description 2
• 239000007922 nasal spray Substances 0.000 description 2
• 229940097496 nasal spray Drugs 0.000 description 2
• 239000006199 nebulizer Substances 0.000 description 2
• 231100000252 nontoxic Toxicity 0.000 description 2
• 230000003000 nontoxic effect Effects 0.000 description 2
• 150000007530 organic bases Chemical class 0.000 description 2
• 238000004806 packaging method and process Methods 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 229920002401 polyacrylamide Polymers 0.000 description 2
• 108091033319 polynucleotide Proteins 0.000 description 2
• 102000040430 polynucleotide Human genes 0.000 description 2
• 239000002157 polynucleotide Substances 0.000 description 2
• 229920000136 polysorbate Polymers 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 238000011321 prophylaxis Methods 0.000 description 2
• 230000005855 radiation Effects 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 238000002741 site-directed mutagenesis Methods 0.000 description 2
• 239000011734 sodium Substances 0.000 description 2
• 229910052708 sodium Inorganic materials 0.000 description 2
• PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
• 210000000952 spleen Anatomy 0.000 description 2
• 239000007921 spray Substances 0.000 description 2
• 230000006641 stabilisation Effects 0.000 description 2
• 238000011105 stabilization Methods 0.000 description 2
• 239000008107 starch Substances 0.000 description 2
• 150000003432 sterols Chemical class 0.000 description 2
• 235000003702 sterols Nutrition 0.000 description 2
• 230000004936 stimulating effect Effects 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000007929 subcutaneous injection Substances 0.000 description 2
• 238000010254 subcutaneous injection Methods 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 150000008163 sugars Chemical class 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 208000011580 syndromic disease Diseases 0.000 description 2
• 230000005737 synergistic response Effects 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 239000006188 syrup Substances 0.000 description 2
• 235000020357 syrup Nutrition 0.000 description 2
• 239000000454 talc Substances 0.000 description 2
• 229910052623 talc Inorganic materials 0.000 description 2
• 235000012222 talc Nutrition 0.000 description 2
• 210000001541 thymus gland Anatomy 0.000 description 2
• 239000003104 tissue culture media Substances 0.000 description 2
• 238000012546 transfer Methods 0.000 description 2
• 150000003626 triacylglycerols Chemical class 0.000 description 2
• 102000003390 tumor necrosis factor Human genes 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 2
• 229940045145 uridine Drugs 0.000 description 2
• 208000007089 vaccinia Diseases 0.000 description 2
• 230000002477 vacuolizing effect Effects 0.000 description 2
• 239000000277 virosome Substances 0.000 description 2
• 229940051021 yellow-fever virus Drugs 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
• DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
• GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 description 1
• WKCJTSHOKDLADL-UHFFFAOYSA-N 1-aminocyclopropylphosphonic acid Chemical compound OP(=O)(O)C1(N)CC1 WKCJTSHOKDLADL-UHFFFAOYSA-N 0.000 description 1
• IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
• QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
• ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
• HZLCGUXUOFWCCN-UHFFFAOYSA-N 2-hydroxynonadecane-1,2,3-tricarboxylic acid Chemical compound CCCCCCCCCCCCCCCCC(C(O)=O)C(O)(C(O)=O)CC(O)=O HZLCGUXUOFWCCN-UHFFFAOYSA-N 0.000 description 1
• 108091071337 20 family Proteins 0.000 description 1
• 101150110188 30 gene Proteins 0.000 description 1
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
• FVFVNNKYKYZTJU-UHFFFAOYSA-N 6-chloro-1,3,5-triazine-2,4-diamine Chemical group NC1=NC(N)=NC(Cl)=N1 FVFVNNKYKYZTJU-UHFFFAOYSA-N 0.000 description 1
• 244000215068 Acacia senegal Species 0.000 description 1
• 241000186041 Actinomyces israelii Species 0.000 description 1
• 102000055025 Adenosine deaminases Human genes 0.000 description 1
• 101000689231 Aeromonas salmonicida S-layer protein Proteins 0.000 description 1
• 241000120516 African horse sickness virus Species 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 241000209136 Agropyron Species 0.000 description 1
• 241000743339 Agrostis Species 0.000 description 1
• 240000005611 Agrostis gigantea Species 0.000 description 1
• 241001135972 Aleutian mink disease virus Species 0.000 description 1
• 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• 241000710929 Alphavirus Species 0.000 description 1
• 241000223600 Alternaria Species 0.000 description 1
• 241000223602 Alternaria alternata Species 0.000 description 1
• 206010002199 Anaphylactic shock Diseases 0.000 description 1
• 241000252073 Anguilliformes Species 0.000 description 1
• 241000743857 Anthoxanthum Species 0.000 description 1
• 240000004178 Anthoxanthum odoratum Species 0.000 description 1
• 235000014251 Anthoxanthum odoratum Nutrition 0.000 description 1
• 241000269350 Anura Species 0.000 description 1
• 241000272478 Aquila Species 0.000 description 1
• 241000473391 Archosargus rhomboidalis Species 0.000 description 1
• 241001167018 Aroa Species 0.000 description 1
• 241000508787 Arrhenatherum Species 0.000 description 1
• 241000508786 Arrhenatherum elatius Species 0.000 description 1
• 235000003826 Artemisia Nutrition 0.000 description 1
• 235000004355 Artemisia lactiflora Nutrition 0.000 description 1
• 241000416162 Astragalus gummifer Species 0.000 description 1
• 206010003591 Ataxia Diseases 0.000 description 1
• 241000701061 Ateline gammaherpesvirus 2 Species 0.000 description 1
• 206010003694 Atrophy Diseases 0.000 description 1
• 241000972773 Aulopiformes Species 0.000 description 1
• 208000023275 Autoimmune disease Diseases 0.000 description 1
• 235000005781 Avena Nutrition 0.000 description 1
• 244000075850 Avena orientalis Species 0.000 description 1
• 241000701802 Aviadenovirus Species 0.000 description 1
• 241001213911 Avian retroviruses Species 0.000 description 1
• 241000700663 Avipoxvirus Species 0.000 description 1
• 230000003844 B-cell-activation Effects 0.000 description 1
• 108010071023 Bacterial Outer Membrane Proteins Proteins 0.000 description 1
• 241001148536 Bacteroides sp. Species 0.000 description 1
• 241000219429 Betula Species 0.000 description 1
• 235000003932 Betula Nutrition 0.000 description 1
• 241000219430 Betula pendula Species 0.000 description 1
• 235000009109 Betula pendula Nutrition 0.000 description 1
• 241000219495 Betulaceae Species 0.000 description 1
• 241000702628 Birnaviridae Species 0.000 description 1
• 241000237519 Bivalvia Species 0.000 description 1
• 241000228405 Blastomyces dermatitidis Species 0.000 description 1
• 241000238658 Blattella Species 0.000 description 1
• 241000238657 Blattella germanica Species 0.000 description 1
• 241000120506 Bluetongue virus Species 0.000 description 1
• 241000589969 Borreliella burgdorferi Species 0.000 description 1
• 241000701083 Bovine alphaherpesvirus 1 Species 0.000 description 1
• 241000621124 Bovine papular stomatitis virus Species 0.000 description 1
• 241000701922 Bovine parvovirus Species 0.000 description 1
• 241001506128 Bovine rotavirus strain NCDV/G6 Species 0.000 description 1
• 208000003174 Brain Neoplasms Diseases 0.000 description 1
• 208000026310 Breast neoplasm Diseases 0.000 description 1
• 241000209200 Bromus Species 0.000 description 1
• 241000743756 Bromus inermis Species 0.000 description 1
• 208000027312 Bursal disease Diseases 0.000 description 1
• 108010029697 CD40 Ligand Proteins 0.000 description 1
• 102100032937 CD40 ligand Human genes 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000589994 Campylobacter sp. Species 0.000 description 1
• 241000222122 Candida albicans Species 0.000 description 1
• 241000701931 Canine parvovirus Species 0.000 description 1
• 241000282465 Canis Species 0.000 description 1
• 241000700664 Capripoxvirus Species 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• 101710132601 Capsid protein Proteins 0.000 description 1
• 241000879755 Caracal Species 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 208000009458 Carcinoma in Situ Diseases 0.000 description 1
• 241000710190 Cardiovirus Species 0.000 description 1
• 241000700199 Cavia porcellus Species 0.000 description 1
• 241000238366 Cephalopoda Species 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 241000723437 Chamaecyparis Species 0.000 description 1
• 241000711969 Chandipura virus Species 0.000 description 1
• 241001227713 Chiron Species 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 241000606153 Chlamydia trachomatis Species 0.000 description 1
• 208000006332 Choriocarcinoma Diseases 0.000 description 1
• 241000193403 Clostridium Species 0.000 description 1
• 241000193449 Clostridium tetani Species 0.000 description 1
• 241000223205 Coccidioides immitis Species 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 241000204955 Colorado tick fever virus Species 0.000 description 1
• 206010010741 Conjunctivitis Diseases 0.000 description 1
• 206010010947 Coordination abnormal Diseases 0.000 description 1
• 241000759568 Corixa Species 0.000 description 1
• 229920002261 Corn starch Polymers 0.000 description 1
• 102100028233 Coronin-1A Human genes 0.000 description 1
• 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
• 241000186249 Corynebacterium sp. Species 0.000 description 1
• 241000709687 Coxsackievirus Species 0.000 description 1
• 108091029523 CpG island Proteins 0.000 description 1
• 208000020406 Creutzfeldt Jacob disease Diseases 0.000 description 1
• 208000003407 Creutzfeldt-Jakob Syndrome Diseases 0.000 description 1
• 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 1
• MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 241000723198 Cupressus Species 0.000 description 1
• 244000301850 Cupressus sempervirens Species 0.000 description 1
• 101710112752 Cytotoxin Proteins 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
• HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 108010041986 DNA Vaccines Proteins 0.000 description 1
• 229940021995 DNA vaccine Drugs 0.000 description 1
• 241000209210 Dactylis Species 0.000 description 1
• 240000004585 Dactylis glomerata Species 0.000 description 1
• 241000238557 Decapoda Species 0.000 description 1
• 241000584340 Dendropanax hoi Species 0.000 description 1
• 241000710829 Dengue virus group Species 0.000 description 1
• 241000238710 Dermatophagoides Species 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 206010012735 Diarrhoea Diseases 0.000 description 1
• 241000723298 Dicentrarchus labrax Species 0.000 description 1
• 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 241000710945 Eastern equine encephalitis virus Species 0.000 description 1
• 241001466953 Echovirus Species 0.000 description 1
• 208000006586 Ectromelia Diseases 0.000 description 1
• 241000607471 Edwardsiella tarda Species 0.000 description 1
• LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
• 241000508725 Elymus repens Species 0.000 description 1
• 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
• 241000710188 Encephalomyocarditis virus Species 0.000 description 1
• 206010014733 Endometrial cancer Diseases 0.000 description 1
• 206010014759 Endometrial neoplasm Diseases 0.000 description 1
• 102100031780 Endonuclease Human genes 0.000 description 1
• 241000792859 Enema Species 0.000 description 1
• 241000588914 Enterobacter Species 0.000 description 1
• 241000194032 Enterococcus faecalis Species 0.000 description 1
• 241001495410 Enterococcus sp. Species 0.000 description 1
• 241000988559 Enterovirus A Species 0.000 description 1
• 241000709691 Enterovirus E Species 0.000 description 1
• 102000004190 Enzymes Human genes 0.000 description 1
• 108090000790 Enzymes Proteins 0.000 description 1
• 241000701089 Equid alphaherpesvirus 4 Species 0.000 description 1
• 208000000832 Equine Encephalomyelitis Diseases 0.000 description 1
• 241000186810 Erysipelothrix rhusiopathiae Species 0.000 description 1
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
• 108700039887 Essential Genes Proteins 0.000 description 1
• 241000282323 Felidae Species 0.000 description 1
• 241000725579 Feline coronavirus Species 0.000 description 1
• 241000701915 Feline panleukopenia virus Species 0.000 description 1
• 241001280522 Feline picornavirus Species 0.000 description 1
• 241000879809 Felis margarita Species 0.000 description 1
• 241000234642 Festuca Species 0.000 description 1
• 241000234645 Festuca pratensis Species 0.000 description 1
• 241000711950 Filoviridae Species 0.000 description 1
• 241000710781 Flaviviridae Species 0.000 description 1
• 241000710831 Flavivirus Species 0.000 description 1
• 241000604777 Flavobacterium columnare Species 0.000 description 1
• 208000004262 Food Hypersensitivity Diseases 0.000 description 1
• 208000007212 Foot-and-Mouth Disease Diseases 0.000 description 1
• 208000000666 Fowlpox Diseases 0.000 description 1
• 206010017533 Fungal infection Diseases 0.000 description 1
• 206010017553 Furuncle Diseases 0.000 description 1
• 241000605909 Fusobacterium Species 0.000 description 1
• 102000030782 GTP binding Human genes 0.000 description 1
• 241000701063 Gallid alphaherpesvirus 1 Species 0.000 description 1
• 208000005577 Gastroenteritis Diseases 0.000 description 1
• 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
• 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
• 241001506229 Goose reovirus Species 0.000 description 1
• 229920000084 Gum arabic Polymers 0.000 description 1
• 241000057766 Gymnostoma chamaecyparis Species 0.000 description 1
• 208000031886 HIV Infections Diseases 0.000 description 1
• 241000606768 Haemophilus influenzae Species 0.000 description 1
• 206010061192 Haemorrhagic fever Diseases 0.000 description 1
• 241000150562 Hantaan orthohantavirus Species 0.000 description 1
• 241000713858 Harvey murine sarcoma virus Species 0.000 description 1
• 241000590002 Helicobacter pylori Species 0.000 description 1
• 108010006464 Hemolysin Proteins Proteins 0.000 description 1
• 208000032843 Hemorrhage Diseases 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• 208000005331 Hepatitis D Diseases 0.000 description 1
• 208000007514 Herpes zoster Diseases 0.000 description 1
• 241000701020 Herpesvirus sylvilagus Species 0.000 description 1
• 241000226709 Hesperocyparis arizonica Species 0.000 description 1
• 241001290232 Hesperocyparis macrocarpa Species 0.000 description 1
• 241000228404 Histoplasma capsulatum Species 0.000 description 1
• 241000744855 Holcus Species 0.000 description 1
• 240000003857 Holcus lanatus Species 0.000 description 1
• 241001272567 Hominoidea Species 0.000 description 1
• 101000959820 Homo sapiens Interferon alpha-1/13 Proteins 0.000 description 1
• 241000714260 Human T-lymphotropic virus 1 Species 0.000 description 1
• 241000714259 Human T-lymphotropic virus 2 Species 0.000 description 1
• 241000701085 Human alphaherpesvirus 3 Species 0.000 description 1
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 1
• 244000309469 Human enteric coronavirus Species 0.000 description 1
• 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
• 241000701806 Human papillomavirus Species 0.000 description 1
• 241000829111 Human polyomavirus 1 Species 0.000 description 1
• 241000430519 Human rhinovirus sp. Species 0.000 description 1
• 241000617996 Human rotavirus Species 0.000 description 1
• 102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
• 108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 1
• XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
• 206010065042 Immune reconstitution inflammatory syndrome Diseases 0.000 description 1
• 208000004467 Infectious Canine Hepatitis Diseases 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 108090000176 Interleukin-13 Proteins 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 108010002350 Interleukin-2 Proteins 0.000 description 1
• 102000000588 Interleukin-2 Human genes 0.000 description 1
• 108010002386 Interleukin-3 Proteins 0.000 description 1
• 108010002586 Interleukin-7 Proteins 0.000 description 1
• 108010002335 Interleukin-9 Proteins 0.000 description 1
• 241000701460 JC polyomavirus Species 0.000 description 1
• 241000710842 Japanese encephalitis virus Species 0.000 description 1
• 241000721668 Juniperus ashei Species 0.000 description 1
• 241000592238 Juniperus communis Species 0.000 description 1
• 241000701646 Kappapapillomavirus 2 Species 0.000 description 1
• 241000120527 Kemerovo virus Species 0.000 description 1
• 208000008839 Kidney Neoplasms Diseases 0.000 description 1
• 241000588747 Klebsiella pneumoniae Species 0.000 description 1
• 101001056675 Klebsiella pneumoniae Ferric aerobactin receptor Proteins 0.000 description 1
• 241000186660 Lactobacillus Species 0.000 description 1
• 241000712902 Lassa mammarenavirus Species 0.000 description 1
• 241000589248 Legionella Species 0.000 description 1
• 208000007764 Legionnaires' Disease Diseases 0.000 description 1
• 241000222722 Leishmania <genus> Species 0.000 description 1
• 241000700563 Leporipoxvirus Species 0.000 description 1
• 241000589902 Leptospira Species 0.000 description 1
• 206010024503 Limb reduction defect Diseases 0.000 description 1
• 241000239218 Limulus Species 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 241000186779 Listeria monocytogenes Species 0.000 description 1
• 241000209082 Lolium Species 0.000 description 1
• 244000100545 Lolium multiflorum Species 0.000 description 1
• 240000004296 Lolium perenne Species 0.000 description 1
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 206010025323 Lymphomas Diseases 0.000 description 1
• 241000721701 Lynx Species 0.000 description 1
• 241000711828 Lyssavirus Species 0.000 description 1
• 241000316144 Macrodon ancylodon Species 0.000 description 1
• 235000019759 Maize starch Nutrition 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 208000006758 Marek Disease Diseases 0.000 description 1
• 241000701244 Mastadenovirus Species 0.000 description 1
• 108010052285 Membrane Proteins Proteins 0.000 description 1
• 102000018697 Membrane Proteins Human genes 0.000 description 1
• 241000710185 Mengo virus Species 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 241000713333 Mouse mammary tumor virus Species 0.000 description 1
• 208000003445 Mouth Neoplasms Diseases 0.000 description 1
• 241000204795 Muraena helena Species 0.000 description 1
• 241000711466 Murine hepatitis virus Species 0.000 description 1
• 241001135960 Murine rotavirus Species 0.000 description 1
• 241000186367 Mycobacterium avium Species 0.000 description 1
• 241000187484 Mycobacterium gordonae Species 0.000 description 1
• 241000186363 Mycobacterium kansasii Species 0.000 description 1
• 208000031888 Mycoses Diseases 0.000 description 1
• 241000588652 Neisseria gonorrhoeae Species 0.000 description 1
• 206010029260 Neuroblastoma Diseases 0.000 description 1
• 244000061176 Nicotiana tabacum Species 0.000 description 1
• 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
• 241000714209 Norwalk virus Species 0.000 description 1
• 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
• 101710141454 Nucleoprotein Proteins 0.000 description 1
• 102000011931 Nucleoproteins Human genes 0.000 description 1
• 108010061100 Nucleoproteins Proteins 0.000 description 1
• 241000710944 O'nyong-nyong virus Species 0.000 description 1
• QWZRZYWLWTWVLF-UHFFFAOYSA-N O.OP(O)=O Chemical compound O.OP(O)=O QWZRZYWLWTWVLF-UHFFFAOYSA-N 0.000 description 1
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
• 241001327682 Oncorhynchus mykiss irideus Species 0.000 description 1
• 241000702259 Orbivirus Species 0.000 description 1
• 241000700629 Orthopoxvirus Species 0.000 description 1
• 241000702244 Orthoreovirus Species 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 241000237502 Ostreidae Species 0.000 description 1
• 206010033128 Ovarian cancer Diseases 0.000 description 1
• 206010061535 Ovarian neoplasm Diseases 0.000 description 1
• 241001474977 Palla Species 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 206010033799 Paralysis Diseases 0.000 description 1
• 241000700639 Parapoxvirus Species 0.000 description 1
• 208000030852 Parasitic disease Diseases 0.000 description 1
• 206010033976 Paravaccinia Diseases 0.000 description 1
• 241000721464 Parietaria officinalis Species 0.000 description 1
• 241000701945 Parvoviridae Species 0.000 description 1
• 241001330453 Paspalum Species 0.000 description 1
• 241001330451 Paspalum notatum Species 0.000 description 1
• 241000606860 Pasteurella Species 0.000 description 1
• 206010034107 Pasteurella infections Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
• 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 241000238661 Periplaneta Species 0.000 description 1
• 241000238675 Periplaneta americana Species 0.000 description 1
• 108010081690 Pertussis Toxin Proteins 0.000 description 1
• 241000745991 Phalaris Species 0.000 description 1
• 244000081757 Phalaris arundinacea Species 0.000 description 1
• 241000255129 Phlebotominae Species 0.000 description 1
• 241000746981 Phleum Species 0.000 description 1
• 241000746983 Phleum pratense Species 0.000 description 1
• 206010035148 Plague Diseases 0.000 description 1
• 241001127637 Plantago Species 0.000 description 1
• 244000239204 Plantago lanceolata Species 0.000 description 1
• 235000010503 Plantago lanceolata Nutrition 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 241000223960 Plasmodium falciparum Species 0.000 description 1
• 241000223821 Plasmodium malariae Species 0.000 description 1
• 241001505293 Plasmodium ovale Species 0.000 description 1
• 241000223810 Plasmodium vivax Species 0.000 description 1
• 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
• 241000209048 Poa Species 0.000 description 1
• 241000136254 Poa compressa Species 0.000 description 1
• 241000209049 Poa pratensis Species 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 239000002202 Polyethylene glycol Substances 0.000 description 1
• 229920001710 Polyorthoester Polymers 0.000 description 1
• 239000004793 Polystyrene Substances 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 208000027954 Poultry disease Diseases 0.000 description 1
• 208000024777 Prion disease Diseases 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 241000589516 Pseudomonas Species 0.000 description 1
• 241000282374 Puma concolor Species 0.000 description 1
• KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
• 206010037660 Pyrexia Diseases 0.000 description 1
• 102000013009 Pyruvate Kinase Human genes 0.000 description 1
• 108020005115 Pyruvate Kinase Proteins 0.000 description 1
• 241000219492 Quercus Species 0.000 description 1
• 244000274906 Quercus alba Species 0.000 description 1
• 235000009137 Quercus alba Nutrition 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 206010038389 Renal cancer Diseases 0.000 description 1
• 241000186812 Renibacterium salmoninarum Species 0.000 description 1
• 241000702263 Reovirus sp. Species 0.000 description 1
• 208000018569 Respiratory Tract disease Diseases 0.000 description 1
• 206010038997 Retroviral infections Diseases 0.000 description 1
• 241000712907 Retroviridae Species 0.000 description 1
• 206010039085 Rhinitis allergic Diseases 0.000 description 1
• 206010051497 Rhinotracheitis Diseases 0.000 description 1
• PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 244000004774 Sabina virginiana Species 0.000 description 1
• 235000008691 Sabina virginiana Nutrition 0.000 description 1
• 241000282695 Saimiri Species 0.000 description 1
• 241000277293 Salvelinus alpinus Species 0.000 description 1
• 241000714213 San Miguel sea lion virus Species 0.000 description 1
• 241001135555 Sandfly fever Sicilian virus Species 0.000 description 1
• 241000209056 Secale Species 0.000 description 1
• 244000082988 Secale cereale Species 0.000 description 1
• 235000007238 Secale cereale Nutrition 0.000 description 1
• 241000710961 Semliki Forest virus Species 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• SBMNPABNWKXNBJ-BQBZGAKWSA-N Ser-Lys Chemical group NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](N)CO SBMNPABNWKXNBJ-BQBZGAKWSA-N 0.000 description 1
• 241000607768 Shigella Species 0.000 description 1
• 241000713311 Simian immunodeficiency virus Species 0.000 description 1
• 241000702677 Simian rotavirus Species 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 1
• 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
• 241000295644 Staphylococcaceae Species 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 108091081024 Start codon Proteins 0.000 description 1
• 240000006694 Stellaria media Species 0.000 description 1
• 208000005718 Stomach Neoplasms Diseases 0.000 description 1
• 241001478880 Streptobacillus moniliformis Species 0.000 description 1
• 241000193985 Streptococcus agalactiae Species 0.000 description 1
• 241000194049 Streptococcus equinus Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000193996 Streptococcus pyogenes Species 0.000 description 1
• 241001505901 Streptococcus sp. 'group A' Species 0.000 description 1
• 241000193990 Streptococcus sp. 'group B' Species 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 241000701093 Suid alphaherpesvirus 1 Species 0.000 description 1
• 241000700568 Suipoxvirus Species 0.000 description 1
• 206010042566 Superinfection Diseases 0.000 description 1
• 230000005867 T cell response Effects 0.000 description 1
• 208000000389 T-cell leukemia Diseases 0.000 description 1
• 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
• 108700026226 TATA Box Proteins 0.000 description 1
• 241000712908 Tacaribe mammarenavirus Species 0.000 description 1
• 208000031320 Teratogenesis Diseases 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 101000748795 Thermus thermophilus (strain ATCC 27634 / DSM 579 / HB8) Cytochrome c oxidase polypeptide I+III Proteins 0.000 description 1
• 102000006601 Thymidine Kinase Human genes 0.000 description 1
• 108020004440 Thymidine kinase Proteins 0.000 description 1
• 208000024770 Thyroid neoplasm Diseases 0.000 description 1
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 1
• 241000223997 Toxoplasma gondii Species 0.000 description 1
• 229920001615 Tragacanth Polymers 0.000 description 1
• 241000589886 Treponema Species 0.000 description 1
• 241000589904 Treponema pallidum subsp. pertenue Species 0.000 description 1
• 239000007983 Tris buffer Substances 0.000 description 1
• 241000209140 Triticum Species 0.000 description 1
• 235000021307 Triticum Nutrition 0.000 description 1
• 244000098338 Triticum aestivum Species 0.000 description 1
• 238000010162 Tukey test Methods 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 241000700647 Variola virus Species 0.000 description 1
• 241001494970 Vesicular exanthema of swine virus Species 0.000 description 1
• 241001135139 Vibrio ordalii Species 0.000 description 1
• 206010058874 Viraemia Diseases 0.000 description 1
• 208000036142 Viral infection Diseases 0.000 description 1
• 208000010094 Visna Diseases 0.000 description 1
• 241000713325 Visna/maedi virus Species 0.000 description 1
• 241000120645 Yellow fever virus group Species 0.000 description 1
• 206010048249 Yersinia infections Diseases 0.000 description 1
• 208000025079 Yersinia infectious disease Diseases 0.000 description 1
• 235000010489 acacia gum Nutrition 0.000 description 1
• 239000000205 acacia gum Substances 0.000 description 1
• 231100000230 acceptable toxicity Toxicity 0.000 description 1
• VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical compound CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 description 1
• DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
• 230000003213 activating effect Effects 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 102000030621 adenylate cyclase Human genes 0.000 description 1
• 108060000200 adenylate cyclase Proteins 0.000 description 1
• 230000000145 adjuvantlike effect Effects 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 235000010419 agar Nutrition 0.000 description 1
• 229940040563 agaric acid Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 239000000783 alginic acid Substances 0.000 description 1
• 229960001126 alginic acid Drugs 0.000 description 1
• 150000004781 alginic acids Chemical class 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 125000005600 alkyl phosphonate group Chemical group 0.000 description 1
• 201000010105 allergic rhinitis Diseases 0.000 description 1
• HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
• AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 238000003277 amino acid sequence analysis Methods 0.000 description 1
• 230000003444 anaesthetic effect Effects 0.000 description 1
• 238000000540 analysis of variance Methods 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 208000003455 anaphylaxis Diseases 0.000 description 1
• 230000003466 anti-cipated effect Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 210000000612 antigen-presenting cell Anatomy 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000008135 aqueous vehicle Substances 0.000 description 1
• 101150037081 aroA gene Proteins 0.000 description 1
• 235000009052 artemisia Nutrition 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 239000010425 asbestos Substances 0.000 description 1
• 244000309743 astrovirus Species 0.000 description 1
• 230000037444 atrophy Effects 0.000 description 1
• 230000003190 augmentative effect Effects 0.000 description 1
• 241000701792 avian adenovirus Species 0.000 description 1
• 208000022362 bacterial infectious disease Diseases 0.000 description 1
• 244000052616 bacterial pathogen Species 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 229960000686 benzalkonium chloride Drugs 0.000 description 1
• RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 1
• CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
• 201000009036 biliary tract cancer Diseases 0.000 description 1
• 208000020790 biliary tract neoplasm Diseases 0.000 description 1
• 239000003124 biologic agent Substances 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 210000001124 body fluid Anatomy 0.000 description 1
• KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
• 239000004327 boric acid Substances 0.000 description 1
• 210000001669 bursa of fabricius Anatomy 0.000 description 1
• 229960005084 calcitriol Drugs 0.000 description 1
• GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 159000000007 calcium salts Chemical class 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 229940095731 candida albicans Drugs 0.000 description 1
• 239000001569 carbon dioxide Substances 0.000 description 1
• 229960004424 carbon dioxide Drugs 0.000 description 1
• 239000011545 carbonate/bicarbonate buffer Substances 0.000 description 1
• 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
• 125000002843 carboxylic acid group Chemical group 0.000 description 1
• 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
• 231100000357 carcinogen Toxicity 0.000 description 1
• 239000003183 carcinogenic agent Substances 0.000 description 1
• 241001233037 catfish Species 0.000 description 1
• 230000010261 cell growth Effects 0.000 description 1
• 239000006285 cell suspension Substances 0.000 description 1
• 230000001413 cellular effect Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• 208000015114 central nervous system disease Diseases 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 229940038705 chlamydia trachomatis Drugs 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 150000001840 cholesterol esters Chemical class 0.000 description 1
• 235000020639 clam Nutrition 0.000 description 1
• 101150093710 clec-87 gene Proteins 0.000 description 1
• 238000010367 cloning Methods 0.000 description 1
• 238000011260 co-administration Methods 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 229940110456 cocoa butter Drugs 0.000 description 1
• 235000019868 cocoa butter Nutrition 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000000295 complement effect Effects 0.000 description 1
• 239000007891 compressed tablet Substances 0.000 description 1
• 201000005332 contagious pustular dermatitis Diseases 0.000 description 1
• 238000013270 controlled release Methods 0.000 description 1
• 201000003740 cowpox Diseases 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000012864 cross contamination Methods 0.000 description 1
• 239000000287 crude extract Substances 0.000 description 1
• 230000001461 cytolytic effect Effects 0.000 description 1
• 210000000172 cytosol Anatomy 0.000 description 1
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 1
• 231100000599 cytotoxic agent Toxicity 0.000 description 1
• 239000002619 cytotoxin Substances 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000007123 defense Effects 0.000 description 1
• 239000003405 delayed action preparation Substances 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 239000000645 desinfectant Substances 0.000 description 1
• 238000001784 detoxification Methods 0.000 description 1
• PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 1
• 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
• 229940042935 dichlorodifluoromethane Drugs 0.000 description 1
• 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• BOKOVLFWCAFYHP-UHFFFAOYSA-N dihydroxy-methoxy-sulfanylidene-$l^{5}-phosphane Chemical compound COP(O)(O)=S BOKOVLFWCAFYHP-UHFFFAOYSA-N 0.000 description 1
• 150000002009 diols Chemical class 0.000 description 1
• 230000006806 disease prevention Effects 0.000 description 1
• 239000007884 disintegrant Substances 0.000 description 1
• 239000002270 dispersing agent Substances 0.000 description 1
• 230000009429 distress Effects 0.000 description 1
• 239000006196 drop Substances 0.000 description 1
• 239000000428 dust Substances 0.000 description 1
• 230000013020 embryo development Effects 0.000 description 1
• 201000002491 encephalomyelitis Diseases 0.000 description 1
• 238000013431 end-point dilution ELISA assay Methods 0.000 description 1
• 239000002158 endotoxin Substances 0.000 description 1
• 239000007920 enema Substances 0.000 description 1
• 229940079360 enema for constipation Drugs 0.000 description 1
• 230000013764 eosinophil chemotaxis Effects 0.000 description 1
• 201000004101 esophageal cancer Diseases 0.000 description 1
• LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
• 229940093471 ethyl oleate Drugs 0.000 description 1
• 238000000556 factor analysis Methods 0.000 description 1
• 238000009313 farming Methods 0.000 description 1
• 239000003925 fat Substances 0.000 description 1
• 235000019197 fats Nutrition 0.000 description 1
• 150000004665 fatty acids Chemical class 0.000 description 1
• 206010016629 fibroma Diseases 0.000 description 1
• 108700014844 flt3 ligand Proteins 0.000 description 1
• 235000020932 food allergy Nutrition 0.000 description 1
• 230000037406 food intake Effects 0.000 description 1
• 235000003599 food sweetener Nutrition 0.000 description 1
• 230000037433 frameshift Effects 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 208000003512 furunculosis Diseases 0.000 description 1
• 150000002270 gangliosides Chemical class 0.000 description 1
• 239000007789 gas Substances 0.000 description 1
• 206010017758 gastric cancer Diseases 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 210000004907 gland Anatomy 0.000 description 1
• 125000005456 glyceride group Chemical group 0.000 description 1
• 238000000227 grinding Methods 0.000 description 1
• 229940029575 guanosine Drugs 0.000 description 1
• 210000004524 haematopoietic cell Anatomy 0.000 description 1
• 229940047650 haemophilus influenzae Drugs 0.000 description 1
• 150000008282 halocarbons Chemical class 0.000 description 1
• 230000012447 hatching Effects 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 239000003228 hemolysin Substances 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 208000029570 hepatitis D virus infection Diseases 0.000 description 1
• 244000144980 herd Species 0.000 description 1
• IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
• 210000003630 histaminocyte Anatomy 0.000 description 1
• 210000005260 human cell Anatomy 0.000 description 1
• 230000004727 humoral immunity Effects 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 230000002209 hydrophobic effect Effects 0.000 description 1
• 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
• 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
• 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
• UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
• 230000009610 hypersensitivity Effects 0.000 description 1
• 238000007654 immersion Methods 0.000 description 1
• 230000005965 immune activity Effects 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 229940072221 immunoglobulins Drugs 0.000 description 1
• 239000003018 immunosuppressive agent Substances 0.000 description 1
• 229940125721 immunosuppressive agent Drugs 0.000 description 1
• 230000006057 immunotolerant effect Effects 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 208000033065 inborn errors of immunity Diseases 0.000 description 1
• 208000016290 incoordination Diseases 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000028709 inflammatory response Effects 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 239000002919 insect venom Substances 0.000 description 1
• 238000002743 insertional mutagenesis Methods 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000011835 investigation Methods 0.000 description 1
• 239000003456 ion exchange resin Substances 0.000 description 1
• 229920003303 ion-exchange polymer Polymers 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
• 206010023332 keratitis Diseases 0.000 description 1
• 201000010666 keratoconjunctivitis Diseases 0.000 description 1
• BWHLPLXXIDYSNW-UHFFFAOYSA-N ketorolac tromethamine Chemical compound OCC(N)(CO)CO.OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 BWHLPLXXIDYSNW-UHFFFAOYSA-N 0.000 description 1
• 201000010982 kidney cancer Diseases 0.000 description 1
• 208000017169 kidney disease Diseases 0.000 description 1
• 206010023497 kuru Diseases 0.000 description 1
• 239000004922 lacquer Substances 0.000 description 1
• 229940039696 lactobacillus Drugs 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 239000003446 ligand Substances 0.000 description 1
• 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
• GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
• 229940057995 liquid paraffin Drugs 0.000 description 1
• 201000007270 liver cancer Diseases 0.000 description 1
• 208000014018 liver neoplasm Diseases 0.000 description 1
• 241000238565 lobster Species 0.000 description 1
• 230000005923 long-lasting effect Effects 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 231100000053 low toxicity Toxicity 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 201000005202 lung cancer Diseases 0.000 description 1
• 208000020816 lung neoplasm Diseases 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 210000003563 lymphoid tissue Anatomy 0.000 description 1
• 210000002540 macrophage Anatomy 0.000 description 1
• 235000019359 magnesium stearate Nutrition 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 238000012768 mass vaccination Methods 0.000 description 1
• 230000008774 maternal effect Effects 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000005541 medical transmission Effects 0.000 description 1
• 201000001441 melanoma Diseases 0.000 description 1
• 239000012528 membrane Substances 0.000 description 1
• 210000004379 membrane Anatomy 0.000 description 1
• 229910052751 metal Inorganic materials 0.000 description 1
• 239000002184 metal Substances 0.000 description 1
• 229910021645 metal ion Inorganic materials 0.000 description 1
• 229920000609 methyl cellulose Polymers 0.000 description 1
• 239000001923 methylcellulose Substances 0.000 description 1
• 235000010981 methylcellulose Nutrition 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 244000000010 microbial pathogen Species 0.000 description 1
• 239000003094 microcapsule Substances 0.000 description 1
• 239000011859 microparticle Substances 0.000 description 1
• 208000005871 monkeypox Diseases 0.000 description 1
• 229940035032 monophosphoryl lipid a Drugs 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 230000004682 mucosal barrier function Effects 0.000 description 1
• 230000008881 mucosal defense Effects 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 208000009091 myxoma Diseases 0.000 description 1
• GKTNLYAAZKKMTQ-UHFFFAOYSA-N n-[bis(dimethylamino)phosphinimyl]-n-methylmethanamine Chemical compound CN(C)P(=N)(N(C)C)N(C)C GKTNLYAAZKKMTQ-UHFFFAOYSA-N 0.000 description 1
• 230000031942 natural killer cell mediated cytotoxicity Effects 0.000 description 1
• 239000013642 negative control Substances 0.000 description 1
• 230000000926 neurological effect Effects 0.000 description 1
• 230000002981 neuropathic effect Effects 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 229940023146 nucleic acid vaccine Drugs 0.000 description 1
• 239000002777 nucleoside Substances 0.000 description 1
• 150000003833 nucleoside derivatives Chemical class 0.000 description 1
• 239000007764 o/w emulsion Substances 0.000 description 1
• VQWNELVFHZRFIB-UHFFFAOYSA-N odn 1826 Chemical compound O=C1NC(=O)C(C)=CN1C(O1)CC(O)C1COP(O)(=O)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=O)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=O)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=O)OC1CC(N2C3=NC=NC(N)=C3N=C2)OC1COP(O)(=O)OC1CC(N2C3=C(C(NC(N)=N3)=O)N=C2)OC1COP(O)(=O)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=O)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=O)OC1CC(N2C(N=C(N)C=C2)=O)OC1COP(O)(=O)OC1CC(N2C(NC(=O)C(C)=C2)=O)OC1COP(O)(=O)OC(C(O1)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=O)OC2C(OC(C2)N2C3=C(C(NC(N)=N3)=O)N=C2)COP(O)(=O)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C3=NC=NC(N)=C3N=C2)COP(O)(=O)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C(N=C(N)C=C2)=O)COP(O)(=O)OC2C(OC(C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(O)=O)CC1N1C=C(C)C(=O)NC1=O VQWNELVFHZRFIB-UHFFFAOYSA-N 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 229940124276 oligodeoxyribonucleotide Drugs 0.000 description 1
• 238000002515 oligonucleotide synthesis Methods 0.000 description 1
• 230000014207 opsonization Effects 0.000 description 1
• 229940126578 oral vaccine Drugs 0.000 description 1
• 239000003960 organic solvent Substances 0.000 description 1
• 239000003791 organic solvent mixture Substances 0.000 description 1
• 235000020636 oyster Nutrition 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 208000003154 papilloma Diseases 0.000 description 1
• 230000003071 parasitic effect Effects 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 201000005115 pasteurellosis Diseases 0.000 description 1
• 230000008506 pathogenesis Effects 0.000 description 1
• 230000001575 pathological effect Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 239000012466 permeate Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 239000012071 phase Substances 0.000 description 1
• PTMHPRAIXMAOOB-UHFFFAOYSA-L phosphoramidate Chemical compound NP([O-])([O-])=O PTMHPRAIXMAOOB-UHFFFAOYSA-L 0.000 description 1
• 239000000049 pigment Substances 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 229960002139 pilocarpine hydrochloride Drugs 0.000 description 1
• RNAICSBVACLLGM-GNAZCLTHSA-N pilocarpine hydrochloride Chemical compound Cl.C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C RNAICSBVACLLGM-GNAZCLTHSA-N 0.000 description 1
• 229940118768 plasmodium malariae Drugs 0.000 description 1
• 239000004014 plasticizer Substances 0.000 description 1
• 229920001610 polycaprolactone Polymers 0.000 description 1
• 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
• 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
• 229920000053 polysorbate 80 Polymers 0.000 description 1
• 229920002223 polystyrene Polymers 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 229920001592 potato starch Polymers 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 230000002335 preservative effect Effects 0.000 description 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
• 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
• 230000001566 pro-viral effect Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000001737 promoting effect Effects 0.000 description 1
• 239000003380 propellant Substances 0.000 description 1
• 229940021993 prophylactic vaccine Drugs 0.000 description 1
• 238000001742 protein purification Methods 0.000 description 1
• 101150002764 purA gene Proteins 0.000 description 1
• 125000000714 pyrimidinyl group Chemical group 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 208000023504 respiratory system disease Diseases 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010242 retro-orbital bleeding Methods 0.000 description 1
• 230000001177 retroviral effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 206010039083 rhinitis Diseases 0.000 description 1
• 229940100486 rice starch Drugs 0.000 description 1
• 229910052895 riebeckite Inorganic materials 0.000 description 1
• 235000019515 salmon Nutrition 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 208000026775 severe diarrhea Diseases 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 235000015424 sodium Nutrition 0.000 description 1
• 235000010413 sodium alginate Nutrition 0.000 description 1
• 239000000661 sodium alginate Substances 0.000 description 1
• 229940005550 sodium alginate Drugs 0.000 description 1
• 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
• 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
• 235000013024 sodium fluoride Nutrition 0.000 description 1
• 239000011775 sodium fluoride Substances 0.000 description 1
• POECFFCNUXZPJT-UHFFFAOYSA-M sodium;carbonic acid;hydrogen carbonate Chemical compound [Na+].OC(O)=O.OC([O-])=O POECFFCNUXZPJT-UHFFFAOYSA-M 0.000 description 1
• 239000007901 soft capsule Substances 0.000 description 1
• 239000012439 solid excipient Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 238000001179 sorption measurement Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 238000007619 statistical method Methods 0.000 description 1
• 239000003270 steroid hormone Substances 0.000 description 1
• 201000011549 stomach cancer Diseases 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 229940031626 subunit vaccine Drugs 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 239000013589 supplement Substances 0.000 description 1
• 239000002511 suppository base Substances 0.000 description 1
• 239000000375 suspending agent Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 239000003765 sweetening agent Substances 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 230000009044 synergistic interaction Effects 0.000 description 1
• 238000007910 systemic administration Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 238000012360 testing method Methods 0.000 description 1
• UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• 206010043554 thrombocytopenia Diseases 0.000 description 1
• 201000002510 thyroid cancer Diseases 0.000 description 1
• 210000001578 tight junction Anatomy 0.000 description 1
• 239000004408 titanium dioxide Substances 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000032258 transport Effects 0.000 description 1
• 238000011269 treatment regimen Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 description 1
• 229940029284 trichlorofluoromethane Drugs 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
• 201000008827 tuberculosis Diseases 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 230000029069 type 2 immune response Effects 0.000 description 1
• 230000005951 type IV hypersensitivity Effects 0.000 description 1
• 208000027930 type IV hypersensitivity disease Diseases 0.000 description 1
• 241000990167 unclassified Simian adenoviruses Species 0.000 description 1
• 241000724775 unclassified viruses Species 0.000 description 1
• 229940035893 uracil Drugs 0.000 description 1
• 201000006266 variola major Diseases 0.000 description 1
• 201000000627 variola minor Diseases 0.000 description 1
• 208000014016 variola minor infection Diseases 0.000 description 1
• 231100000611 venom Toxicity 0.000 description 1
• 230000007501 viral attachment Effects 0.000 description 1
• 230000009385 viral infection Effects 0.000 description 1
• 239000001993 wax Substances 0.000 description 1
• 238000005303 weighing Methods 0.000 description 1
• 229940100445 wheat starch Drugs 0.000 description 1